Literature DB >> 7660221

Bronchiolitis obliterans organizing pneumonia cured by standard dose inhaled triamcinolone: the first documented case.

D Watson1, J J Fadem.   

Abstract

Bronchiolitis obliterans organizing pneumonia (BOOP) is characterized clinically by progressive cough, fever, and dyspnea and pathologically by plugging of the bronchiolar and alveolar lumen with buds of loose connective tissue containing fibroblasts and inflammatory cells. The radiographic appearance of the disease varies. Definitive diagnosis requires the histologic identification of the disease in the appropriate clinical setting. Tissue may be obtained by bronchoscopy, needle biopsy, or open lung biopsy. BOOP is responsive to oral corticosteroids, which are the mainstay of therapy. We report the case of a 30-year-old white woman who had BOOP diagnosed in 1991 after extensive therapy for stage II nodular sclerosis Hodgkin's disease. Appropriate treatment of this patient would have been oral corticosteroids for 6 to 12 months, but the patient refused because of a history of significant steroid side effects. Inhaled triamcinolone (3 puffs 4 times per day by metered dose inhaler) for 8 months resulted in complete resolution of the disease. We believe this is the first documented case of clinical and histopathologically confirmed BOOP cured with inhaled corticosteroids.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7660221     DOI: 10.1097/00007611-199509000-00020

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  3 in total

1.  BOOP as a rare complication of gemcitabine therapy.

Authors:  Hameem I Kawsar; Timothy P Spiro; Amy Cocco; Hamed A Daw
Journal:  BMJ Case Rep       Date:  2011-07-20

Review 2.  Cryptogenic organizing pneumonia associated with invasive pulmonary aspergillosis: a case report and review of the literature.

Authors:  Shuanshuan Xie; Changxing Shen; Yunfeng Zhang; Kun Lu; Feng Hu; Min Tan; Haiyan Lin; Lei Xu; Qing Yuan; Xiaolian Song; Changhui Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

3.  Is there a place for anti-inflammatory therapy in COVID-19?

Authors:  Wing Wai Yew; Kwok Chiu Chang; Denise P Chan
Journal:  J Thorac Dis       Date:  2020-11       Impact factor: 2.895

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.